MSDS | : | Iodobenzene diacetate, 98% | CAS | : | 3240-34-4 | SYNONYMS | : | (Diacetoxyiodo)benzene; Iodosobenzene diacetate; PIA; Benzene, diacetoxyiodo-; Benzene, iodoso-, diacetate; Bis(acetato-O)phenyliodine; Iodine, bis(acetato-kappa-O)phenyl-; Iodine, bis(acetato-O)phenyl-; |
| |
|
|
**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 3240-34-4 |Iodobenzene diacetate | 98 | 221-808-1 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.Light sensitive.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea.
Inhalation:
Causes respiratory tract irritation. Can produce delayed pulmonary
edema.
Chronic:
Effects may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing
is difficult, give oxygen. Get medical aid. Do not use mouth-to-mouth
resuscitation if victim ingested or inhaled the substance; induce
artificial respiration with the aid of a pocket mask equipped with a
one-way valve or other proper respiratory medical device.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Sweep up or absorb material, then place into a suitable clean, dry,
closed container for disposal. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Minimize dust generation and accumulation. Avoid
contact with eyes, skin, and clothing. Avoid ingestion and
inhalation. Use with adequate ventilation. Store protected from
light.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Store
protected from light.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 3240-34-4:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystalline powder
Color: white - almost white
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 163 - 165 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: >161 deg C
Solubility in water: insoluble
Specific Gravity/Density: Not available.
Molecular Formula: C10H11IO4
Molecular Weight: 322.09
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, light, dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, hydrogen iodide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 3240-34-4: DA3525000
LD50/LC50:
Not available.
Carcinogenicity:
Iodobenzene diacetate -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 3240-34-4: No information available.
Canada
CAS# 3240-34-4 is listed on Canada's NDSL List.
CAS# 3240-34-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 3240-34-4 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #5 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
L-Ascorbic acid
| 50-81-7 |
|
L-Asparagine Monohydrate
| 5794-13-8 |
|
L-Tryptophan
| 73-22-3 |
|
L-Tyrosine
| 60-18-4 |
|
L-Methionine
| 63-68-3 |
|
Methyl 5-oxazolecarboxylate, 96%
| 121432-12-0 |
|
L-Histidine
| 71-00-1 |
|
L-Histidine Hydrochloride Monohydrate
| 5934-29-2 |
|
Cycloheptatriene, 90%
| 544-25-2 |
|
2-Iodobenzyl alcohol, 99%
| 5159-41-1 |
|
5-Chlorovaleryl Chloride, 96%
| 1575-61-7 |
|
2-Nitro-p-phenylenediamine, 95-99%
| 5307-14-2 |
|
1,4-Dioxaspiro[4.5]decan-8-ol, 98+%
| 22428-87-1 |
|
Pyrazino[2,3-f]Quinoxaline, 99+%
| 231-23-2 |
|
Lanthanum chloride heptahydrate
| 10025-84-0 |
|
Lanthanum Oxide
| 1312-81-8 |
|
Lanthanum Nitrate Hexahydrate
| 10099-59-9 |
|
2,3-Pentanedione, 97%
| 600-14-6 |
|
Lauric Acid
| 143-07-7 |
|
Alpha-NPO, Scintillation Grade
| 846-63-9 |
|
4-Benzylpiperidine, 98%
| 31252-42-3 |
|
2-(2-Quinoxalinyl)malondialdehyde
| 0-00-0 |
|
4-Nitro-Benzylthiocyanate, 99%
| 13287-49-5 |
|
Methyl vinyl ketone
| 78-94-4 |
|
Lead
| 7439-92-1 |
|
2-Methoxy-5-nitroaniline, 99%
| 99-59-2 |
|
Methyltriphenylphosphonium iodide, 97%
| 2065-66-9 |
|
Lead(II) acetate trihydrate
| 301-04-2 |
|
4-Ethylbiphenyl-4'-carboxylic acid, 98%
| 5731-13-5 |
|
Mono-(Trimethylsilyl)Phosphite
| 91076-68-5 |
|
N-Acetylanthranilic acid, 99%
| 89-52-1 |
|
1,2,2,6,6-Pentamethylpiperidine, 95% (GC)
| 79-55-0 |
|
Dihydrogentrifluoride Polymer-Supported, ca 7 mMol HF/g of Amberlyst
| 12260-12-7 |
|
Lead (II) Chloride
| 7758-95-4 |
|
Triisopropanolamine borate, 98+%
| 101-00-8 |
|
(S)-3-tert.-Butyl-2,5-piperazinedione
| 65016-62-8 |
|
2-Methoxynaphthalene, 98%
| 93-04-9 |
|
Lead chromate
| 7758-97-6 |
|
1-(2'-Thienyl)Ethylmercaptan, 98%
| 94089-02-8 |
|
4-Bromobenzotrifluoride, 99%
| 402-43-7 |
|
Lead Dioxide
| 1309-60-0 |
|
N-Hydroxymaleimide, 97%
| 4814-74-8 |
|
1-Dodecanethiol, 98.5+% (gc)
| 112-55-0 |
|
2,4,6-Trimethylaniline, 97%
| 88-05-1 |
|
Iodobenzene diacetate, 98%
| 3240-34-4 |
|
Trans 2, cis 6-nonadienol, 94%
| 28069-72-9 |
|
1,5-Dihydroxy-1,2,3,4-Tetrahydro-Naphthalene, Tech.
| 40771-26-4 |
|
Acrolein dimethyl acetal, 99%
| 6044-68-4 |
|
Lead(II) nitrate
| 10099-74-8 |
|
Lead Oxide Yellow
| 1317-36-8 |
|
|